NCT04370509 2025-11-19Pembrolizumab With or Without Axitinib for Clear Cell Kidney Cancer in Patients Undergoing SurgeryUniversity of California, San FranciscoPhase 2 Terminated6 enrolled 11 charts
NCT01693822 2024-11-21A-PREDICTInstitute of Cancer Research, United KingdomPhase 2 Completed65 enrolled 15 charts